Abstract
Chronic liver disease affects 855 people per million in the UK. Previous studies have reported that coffee appears protective against the development of abnormal liver enzymes, hepatic fibrosis and cirrhosis. The aim of this study, the first in a Scottish population, was to compare coffee consumption in patients with liver disease and that of control populations to determine correlations between coffee intake and the incidence of non-cancerous liver disease and with Child's-Pugh and model for end-stage liver disease (MELD) scores.
Original language | English |
---|---|
Pages (from-to) | 217-22 |
Number of pages | 6 |
Journal | Scottish Medical Journal |
Volume | 58 |
Issue number | 4 |
DOIs | |
Publication status | Published - Nov 2013 |